Table 1

Demographic and clinical characteristics of the two patient cohorts

Group-1 (dermatology patients, n=100)Group-2 (rheumatology patients, n=100)p Value
Age (years±SD)52.30±13.3249.57±12.510.59
Gender, % male6449
MedicationsTNF inhibitors=39TNF inhibitors=53 
Fumaderm=35Synthetic DMARDs=36
Phototherapy=12Others=11
Ustekinumab=3
Ciclosporin=2
Methotrexate=2
Others=7
Duration of psoriasis (years±SD)28.9±14.4525.38±13.750.62
PASI (score±SD)2.044±1.151.65±2.330.001
% Nail disease, current68770.15
% Nail disease, ever72840.041
% Scalp psoriasis, current5617<0.0001
% Scalp psoriasis, ever91820.06
  • DMARD, disease modifying antirheumatic drug; PASI, Psoriasis Area and Severity Index; TNF, tumour necrosis factor.